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A B S T R A C T
The maintenance of satisfactory quality of life is major concern in majority of patients who elect treatment for local-
ized prostate cancer. We conducted a cross-sectional study to determine sexual function after radical prostatectomy (RP)
and external beam radiotherapy (EBRT). Study population consisted of series of 57 patients with early-stage adeno-
carcinoma of the prostate, treated in our institution in the period from January 2003 till December 2003. Thirty three pa-
tients underwent radical retropubical prostatectomy and 24 patients were treated by primary radical radiotherapy. Pa-
tients have been given the full international index of erectile function (IIEF) questionnaire two to four and six months
after the treatment. Post treatment sexual function in patients treated by EBRT is significantly better than in patients
treated by RP (48,5% vs. 21.57%, p<0,0001). Subgroup analysis reveals that satisfaction with erectile function, main-
taining of sexual intercourse and possibility of ejaculation is better in patients treated by EBRT than in patients treated
by RP (44.67% vs. 11.57%, p <0,0001) as well as general satisfaction with quality of sexual life (48.5% in EBRT group
vs. 21.57% in RP group, p <0,0001). On the other hand, sexual desire remains the same in both groups of patients
(63.75% in EBRT group vs. 60.61% in RP group, p = 0.71). Six months after surgical or radiotherapy treatment erectile
function is almost as twice as worse in patients treated by surgery than in patients treated by radiotherapy.
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Introduction
Prostate cancer is one of the principal medical prob-
lems facing male population in Western countries. Devel-
opment of the prostate specific antigen (PSA) screening
enabled detection of more patients with early-stage local-
ized prostate cancer. Standard treatment options for lo-
calized prostate cancer include surgery, radiotherapy and
active monitoring. All those treatment modalities, in-
cluding watchful waiting, are associated with side effects.
The most common side effects of curative treatment are
urinary and fecal incontinence and erectile dysfunction.
Due to early detection, more frequent treatment of local-
ized disease and long post treatment survival, quality of
life is becoming increasingly important. The mainte-
nance of satisfactory quality of life is major concern in
45% of patients who elect treatment for localized pros-
tate cancer1 and sexual dysfunction has been reported to
be independent factor of poorer health-related quality of
life at 2 years after primary treatment.2
Because there are only few direct comparisons of
treatment options for early stage prostate cancer there
are no sufficient data about comparative efficacy and side
effects. We conducted a cross-sectional study to deter-
mine sexual function after radical prostatectomy (RP)
and external beam radiotherapy (EBRT).
Material and Methods
Patient characteristics
Study population consisted of series of 57 patients
with early-stage adenocarcinoma of the prostate, treated
in our institution in the period from January 2003 till
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December 2003, either by radical surgery or primary ra-
diotherapy. All patients were male, white, median age
was 67 years (range from 65 to 70 years), and had
histological diagnosis confirmed by prostate biopsy in all
cases. Computerized tomography of the abdomen and
pelvis was performed in each patient to exclude patients
with lymphatic dissemination. Patients with distant meta-
stases were not eligible. Choice of treatment depended of pa-
tient characteristics, primarily cardiovascular comorbidity.
Surgery
Thirty three patients underwent radical retropubical
prostatectomy (complete resection of prostate, prostatic
urethra, seminal vesicles and regional lymph nodes).
Radiotherapy
Twenty four patients were treated by primary radical
radiotherapy. Minimum tumor dose of 70 Gy / 35 frac-
tions / 7 weeks was prescribed to the isocenter of a com-
puter-generated plan encompassing the prostate gland
only with a 1.5-cm 95% isodose margin, and radiotherapy
delivered using eight-field external beam megavoltage
(6–23 MV) photon technique. Radiotherapy planning was
based on 2D computed tomography data in all patients.
Protocol
Patients treated either by surgery or radiotherapy,
have been given the full international index of erectile
function (IIEF) questionnaire two to four months after
the treatment. Consistency of the answers has been
tested at consequent control six months after the treat-
ment, and only one answer on every question has been
taken into analysis for each patient. The questionnaire
consists of three parts: set of questions regarding erectile
function, maintaining of sexual intercourse and ejacula-
tion, set of questions regarding patient’s sexual desire,
and set of questions aimed to patient’s satisfaction with
quality of sexual life in general.
Our hypothesis was that patients treated by primary
radiotherapy have better quality of sexual life after the
treatment. Therefore, subjects in both groups should ex-
perience similar sexual desire, while impairment of sexual
function should be greater in surgically treated group.
Statistics
Differences in erectile function between the two groups
of patients were analyzed by chi-square test, and conse-
quently subgroup analysis was also performed in the
same way. P-values reported are from one-sided test.
Results
IIEF score >10 defined potency. After radical prosta-
tectomy potency declined (21,57% vs. 50,6% before treat-
ment, p = 0,0001), while after radiotherapy no statisti-
cally significant worsening has been found (48,5% vs.
50,6%, p = 0,77). Post treatment sexual function in pa-
tients treated by EBRT is significantly better than in pa-
tients treated by RP (48,5% vs. 21,57%, p<0,0001). Sub-
group analysis reveals that satisfaction with erectile
function, maintaining of sexual intercourse and possibil-
ity of ejaculation is better in patients treated by EBRT
than in patients treated by RP (44,67% vs. 11,57%, p
<0,0001) as well as general satisfaction with quality of
sexual life (48,5% in EBRT group vs. 21,57% in RP
group, p <0,0001). On the other hand, sexual desire re-
mains the same in both groups of patients (63,75% in
EBRT group vs. 60,61% in RP group, p = 0,71). All the
results as well as IIEF score are shown in table 1.
Discussion
Results of our cross-sectional study show that six
months after surgical or radiotherapy treatment erectile
function is almost as twice as worse in patients treated
by surgery than in patients treated by radiotherapy.
Since cause of erectile dysfunction is local (i.e. nerve
damage or vascular damage) sexual desire is same and
preserved in both groups of patients. Previous cross-sec-
tional and longitudinal cohort studies also found that
sexual function was more affected in prostatectomy pa-
tients than in radiotherapy patients, for review see3.
These results were confirmed by our study.
It should be noted, however, that this is a cross-sec-
tional study and as such has limitations regarding chan-
ges of erectile function over time. It is known from previ-
ous studies that erectile dysfunction after surgery is
immediate but can be reversible in some patients over
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TABLE 1
ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY OR RADICAL EBRT IN PATIENTS WITH EARLY STAGE PROSTATE
CANCER, BASED ON THE FULL INTERNATIONAL INDEX OF ERECTILE FUNCTION (IIEF) SCORE
RP % EBRT %
Number of patients 33 24
Satisfaction with erectile function, ejaculation and sexual intercourse
11.57% 44.67%
P <0.00001
Sexual desire 60.61% 63.75% P = 0.71128182
Satisfaction with sexual QoL 28.89% 51.11% P = 0.00001239
Total 21.57% 48.5% P <0.00001
RP = radical prostatectomy; EBRT = external beam radiotherapy; QoL = quality of life.
time, while after radiotherapy incidence of erectile dys-
function increases over time.4 That is due to different un-
derlying pathogenesis – erectile dysfunction after sur-
gery is primarily due to neural damage and in minor
extent due to vascular damage.5 However, in the majority
of patients the cause of post-radiotherapy erectile dys-
function is reduction of peak arterial systolic velocity in
cavernosal arteries.6 Therefore sildenafil, according to
some reports, is more efficient in radiotherapy treated
patients than surgically treated patients, as it is more ef-
ficient in surgically treated patients with at least one
nerve bundle spared.7,8,9
Incidence and profile of side effects after treatment of
localized prostate cancer are different in correlation with
treatment modality used. Incidence of side effects is
partly variable whether they are reported by the patient
or by the physician as well. For example, incidence of uri-
nary incontinence varies between 0.3 and 65.6%, and im-
potence between 11 and 87%.10
Factors correlated with better post-surgical erectile
function are younger age, better erections before the sur-
gical procedure, and preservation of neurovascular struc-
tures. If both neurovascular bundles are preserved, erec-
tile function usually recovers within 4 to 6 months.11 If
one of the bundles is damaged during surgery recovery is
usually as twice as long. In cases when disease control re-
quires sacryfing both neurovascular bundles sural nerve
is usually transplanted with modest results. Most of sur-
gically treated patients recover erectile function using
newer vasodilatative drugs like sildenafil, by intraure-
thral alprostandril implantation or intracavernous pros-
taglandin injections.12
In radiotherapy treated patients, prescribed radiation
dose is the main determinant of side effects. Rectal toxic-
ity is observed in 0.7% of patients with tumor dose of
75,6 Gy applied.13 Urethral strictures are observed in
5.2% (range 1.1% to 8.4%) of patients treated by radio-
therapy, and especially in patients who had transurethral
resection of prostate cancer.14 Incidence of erectile dys-
function after radiotherapy depends of quality of erec-
tions before irradiation, applied dose of radiation and
time of evaluation. Since erectile dysfunction after radio-
therapy is caused primarily by vascular damage its inci-
dence increases over time.
Newer surgical techniques including sural nerve trans-
plantation should decrease erectile dysfunction in surgi-
cally treated patients in the future, but newer radiother-
apy planning and application techniques (3D planning,
multileaf collimators) should not be neglected and proba-
bly will result in less radiotherapy-related complications
as well.
In the absence of data from randomized comparative
trials, data from studies such as this could offer valuable
insights in quality of life of prostate cancer survivors.
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SEKS ILI KIRURGIJA – EREKTILNA DISFUNKCIJA NAKON RADIKALNOG LIJE^ENJA
LOKALIZIRANOG RAKA PROSTATE
S A @ E T A K
O~uvanje odgovaraju}e kvalitete `ivota je vrlo bitno bolesnicima koji se lije~e od lokaliziranog raka prostate. Proveli
smo studiju presjeka kako bi utvrdili seksualnu funkciju nakon radikalne prostatektomije (RP) i eksterne radioterapije
(ER). U istra`ivanje je ukju~eno 57 bolesnika sa ranim karcinomom prostate koji su lije~eni u na{oj ustanovi od sije~nja
2003. godine do prosinca 2003. godine. Trideset i tri bolesnika su lije~ena radikalnom retropubi~nom prostatektomijom,
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a 24 primarnom radikalnom radioterapijom. Bolesnici su ispunili me|unarodni upitnik za indeks erektilne funkcije 2
do 4 mjeseca i 6 mjeseci nakon lije~enja. Postterapijska seksualna funkcija je kod bolesnika koji su lije~eni ER zna~ajno
bolja u odnosu na skupinu lije~enu sa RP (48,5% vs. 21,57%, p<0,0001). Dodatne analize su pokazale da je kod bole-
snika lije~enih sa ER zadovoljstvo erektilnom funkcijom, sposobnost odr`avanja spolnog odnosa i mogu}nost ejakulacije
bolja u odnosu na one lije~ene RP (44,67% vs. 11,57%, p <0,0001), te tako|er i op}a kvaliteta spolnog `ivota (48,5% u
ER groupi vs. 21,57% u RP groupi, p <0,0001). Interes za seksulane odnose bio je naprotiv podjednak kod obje skupine
bolesnika Erektilna funkcija je 6 mjeseci nakon kirur{kog ili radioterapijskog lije~enja ranog karcinoma prostate gotovo
dva puta lo{ija kod bolesnika lije~enih RP u odnosu na one lije~enja ER.
V. Lesko Kelovic et al.: Erectile Dysfunction after Radical Treatment of Prostate Cancer, Coll. Antropol. 33 (2009) 2: 529–532
532
